Gilead near deal to buy Immunomedics for more than $20 billion By: MarketWatch September 12, 2020 at 16:01 PM EDT Gilead Sciences Inc. is nearing a deal to buy biotech Immunomedics Inc. and its prized breast-cancer drug for more than $20 billion. Read More >> Related Stocks: Gilead Sciences Immunomedics Inc